This week’s topics include hospital factors relative to readmission, hormone therapy, lymph node dissection in breast cancer, and the cost of bringing a new drug to market.

Program notes:

0:32 Cost of R and D versus profit in new drugs

1:32 Took 7.3 years

2:35 Reaping in sales far outstrips R and D

3:32 R and D with federal dollars

4:00 What is the long term impact of HRT

5:00 Should be reassuring for women

5:36 Lymph node dissection in breast cancer

6:36 Increases risk of complications

7:32 Least amount of therapy to be effective

7:48 Hospital factors in readmission

8:45 Patients readmitted to different hospitals

9:45 Need to correct poorly performing hospitals

10:31 End

Related blog: https://podblog.blogs.hopkinsmedicine.org/2017/09/18/drug-costs/